SIRT1 and ovarian carcinoma: Our results suggest that cytoplasmic SIRT1 inhibits cell migration and invasion by impeding the epithelial–mesenchymal transition (EMT) in ovarian carcinoma, thus providing the first experimental evidence supporting the possible role of SIRT1 subcellular localization in the regulation of ovarian carcinoma progression.